---
figid: PMC9206313__10020_2022_492_Fig2_HTML
figtitle: RCAN1-mediated calcineurin inhibition as a target for cancer therapy
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9206313
filename: 10020_2022_492_Fig2_HTML.jpg
figlink: /pmc/articles/PMC9206313/figure/Fig2/
number: F2
caption: The signaling pathway of RCAN1 in tumor progression. A RCAN1 inhibits CN
  activity by blocking the CN-essential substrate recruitment site, LxVP and PxIxIT
  interaction grooves, by using its LxVP and PxIxIT motif. The inhibition of CN by
  RCAN1 can be weakened by phosphorylation of RCAN1. B RCAN1-regulated CN. RCAN1 inhibits
  CN-NFAT pathway and NFAT-regulated gene transcription, including IGF-1, VEGFA, ANG-2,
  IFI27, CXCL8, IL-8, and IL-11. C CN-independent RCAN1 regulation. GC binds to GREs
  in the RCAN1.1 transcription start site, inducing apoptosis cells. RCAN1 inhibits
  NFE2L3 and the NF-κB signaling pathway
papertitle: RCAN1-mediated calcineurin inhibition as a target for cancer therapy.
reftext: Mengyi Lao, et al. Mol Med. 2022;28:69.
year: '2022'
doi: 10.1186/s10020-022-00492-7
journal_title: Molecular Medicine
journal_nlm_ta: Mol Med
publisher_name: BioMed Central
keywords: RCAN1 | Calcineurin | Cancer therapy
automl_pathway: 0.826043
figid_alias: PMC9206313__F2
figtype: Figure
redirect_from: /figures/PMC9206313__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9206313__10020_2022_492_Fig2_HTML.html
  '@type': Dataset
  description: The signaling pathway of RCAN1 in tumor progression. A RCAN1 inhibits
    CN activity by blocking the CN-essential substrate recruitment site, LxVP and
    PxIxIT interaction grooves, by using its LxVP and PxIxIT motif. The inhibition
    of CN by RCAN1 can be weakened by phosphorylation of RCAN1. B RCAN1-regulated
    CN. RCAN1 inhibits CN-NFAT pathway and NFAT-regulated gene transcription, including
    IGF-1, VEGFA, ANG-2, IFI27, CXCL8, IL-8, and IL-11. C CN-independent RCAN1 regulation.
    GC binds to GREs in the RCAN1.1 transcription start site, inducing apoptosis cells.
    RCAN1 inhibits NFE2L3 and the NF-κB signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1R
  - IGF1
  - CXCL8
  - CXCR2
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PPP3R1
  - PROKR1
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - ITPR1
  - ITPR3
  - VEGFA
  - ANGPT2
  - VPS51
  - CALM1
  - CALM2
  - CALM3
  - KRIT1
  - CAMKMT
  - IL11
  - LONP1
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - KDR
  - RCAN1
  - BRSK2
  - ADRA1D
  - NFKB1
  - GPR162
  - NFE2L3
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - IKBKG
  - GC
  - MAK
  - ALPK3
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
---
